Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XLC vs MRNA✓SelectedUSD · MRNAXLC vs MRNA performance historyLatest closeAs of-1.46%11/17
Stock and ETF performance explorer

XLC vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+55.5%
MRNA return
+168.0%
Excess return
-112.5%
Maximum drawdown
-18.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.5%-3.9%+2.5%-1.4%
7D-2.3%-17.6%+15.2%-1.9%
30D-4.6%-5.1%+0.6%-4.5%
3M-4.7%+220.8%-225.5%-8.1%
6M-8.8%+321.7%-330.5%-13.7%
YTD-9.8%+601.3%-611.0%-17.5%
1Y-4.2%+735.2%-739.4%-13.5%
3Y+55.5%+170.5%-115.0%+43.7%
All+55.5%+168.0%-112.5%+43.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling